As reported earlier, Thomas Weisel initiated MedAssets with an Overweight rating. The firm believes that the company's margins will increase as it achieves scale. Thomas Weisel recommends buying the stock and set a $27 target. :theflyonthewall.com
News For MDAS From The Last 14 Days
Check below for free stories on MDAS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
